Celadon Pharmaceuticals PLC (GB:CEL) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Celadon Pharmaceuticals PLC, a UK-based innovator in cannabis-based medicines, has announced a strategic partnership with Danish firm Valeos Pharma A/S to boost the production and supply of high-THC medical cannabis. The collaboration is expected to significantly increase Celadon’s product yield and quality, while also simplifying the EU-based supply chain, potentially increasing annual production capacity by up to 3 tonnes. This move strategically positions Celadon to expedite its path to profitability and better meet the growing European market demand.
For further insights into GB:CEL stock, check out TipRanks’ Stock Analysis page.
